NYSE$HCA
HCA Holdings Inc · Q2 2026 earnings
Q2 2026 earnings · · Before market open · Investor relations
Briefing
HCA Healthcare reported preliminary Q2 2026 revenues of $20.23 billion and net income of $1.699 billion.
HCA Healthcare previewed second quarter 2026 results with revenues of approximately $20.230 billion, up from $18.605 billion in the prior year. Net income attributable to HCA was $1.699 billion or $7.62 per diluted share, compared to $1.653 billion or $6.83 per share last year. The company revised its full-year 2026 guidance downward due to payer mix shifts from uninsured volumes and other factors.
- Revenues reached $20.230 billion, a 8.7% increase year-over-year.
- Diluted EPS of $7.62 included $0.03 benefit from facility sale gains; adjusted EPS was $7.59.
- Same-facility admissions rose 2.5% and equivalent admissions rose 2.7%, while surgeries declined.
- 2026 guidance was revised lower for revenues, net income, Adjusted EBITDA and EPS due to health insurance exchange impacts.
Headline financials
Revenue & EPS history
HCA · Revenue · Quarterly
$20.2B
Forward guidance
Company revised 2026 guidance ranges lower for revenues, net income, Adjusted EBITDA and EPS.
Tailwinds
- Incremental $400 million net benefit from Medicaid Supplemental Payment Programs recognized in Q2.
Headwinds
- Unfavorable $400 million payer mix shift impact from uninsured volumes in Q2.
- Health insurance exchange impact estimate worsened to ($1.000) to ($1.200) billion for full year.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
-0.1%
Avg return
Earnings day
+0.8%
Avg return
5 days after
+2.9%
Avg return
30 days after
47%
31 / 66 earnings
Positive
+16.1%
Q2 2020
Best reaction
-21.9%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q1 2026 | -5.2% | -8.3% | -16.8% | |
| Q4 2025 | +6.2% | +3.4% | +11.3% | |
| Q3 2025 | +1.5% | +6.4% | +11.6% | |
| Q2 2025 | +0.8% | +3.1% | +3.8% | |
| Q1 2025 | -4.0% | +1.1% | +10.3% | |
| Q4 2024 | -3.8% | +0.7% | -2.7% | |
| Q3 2024 | -10.6% | -9.5% | -18.5% | |
| Q2 2024 | +5.7% | +9.0% | +17.7% | |
| Q1 2024 | -0.9% | -1.5% | +1.5% | |
| Q4 2023 | +6.3% | +7.9% | +8.7% | |
| Q3 2023 | -6.5% | -6.5% | +5.0% | |
| Q2 2023 | -3.2% | -2.9% | -3.2% | |
| Q1 2023 | +5.7% | +2.7% | +4.3% | |
| Q4 2022 | -0.6% | +2.6% | -2.2% | |
| Q3 2022 | +0.8% | +4.3% | +10.3% | |
| Q2 2022 | +9.6% | +12.9% | +18.6% | |
| Q1 2022 | -21.9% | -21.2% | -24.0% | |
| Q4 2021 | -1.4% | -1.1% | +5.5% | |
| Q3 2021 | -7.0% | -5.6% | -8.1% | |
| Q2 2021 | +14.5% | +14.2% | +13.3% | |
| Q1 2021 | +2.5% | +0.7% | +4.5% | |
| Q4 2020 | +3.7% | +5.9% | +5.6% | |
| Q3 2020 | -4.4% | -9.3% | +12.5% | |
| Q2 2020 | +16.1% | +14.6% | +21.2% | |
| Q1 2020 | -5.4% | -2.4% | -2.2% | |
| Q4 2019 | +2.6% | -2.0% | -10.1% | |
| Q3 2019 | +6.2% | +5.3% | +10.3% | |
| Q2 2019 | -8.7% | -13.0% | -17.4% | |
| Q1 2019 | -1.1% | +0.2% | -2.3% | |
| Q4 2018 | +5.6% | +6.1% | +5.5% | |
| Q3 2018 | +3.5% | +4.2% | +12.0% | |
| Q2 2018 | +14.9% | +14.7% | +21.4% | |
| Q1 2018 | +2.1% | +1.9% | +7.7% | |
| Q4 2017 | +3.6% | +2.1% | +1.9% | |
| Q3 2017 | +0.9% | +0.3% | +11.6% | |
| Q2 2017 | -5.2% | -6.6% | -7.9% | |
| Q1 2017 | -1.2% | -0.4% | -0.1% | |
| Q4 2016 | +3.4% | +5.7% | +10.2% | |
| Q3 2016 | -2.1% | -4.5% | -9.6% | |
| Q2 2016 | -1.1% | -3.8% | -4.8% | |
| Q1 2016 | -1.7% | — | — | |
| Q4 2015 | +3.1% | — | — | |
| Q3 2015 | -0.1% | — | — | |
| Q2 2015 | -2.8% | — | — | |
| Q1 2015 | -1.2% | — | — | |
| Q4 2014 | -1.7% | — | — | |
| Q3 2014 | -2.1% | — | — | |
| Q2 2014 | +4.1% | — | — | |
| Q1 2014 | -1.2% | — | — | |
| Q4 2013 | -1.0% | — | — | |
| Q3 2013 | -5.1% | — | — | |
| Q2 2013 | +0.1% | — | — | |
| Q1 2013 | +3.8% | — | — | |
| Q4 2012 | -1.1% | — | — | |
| Q3 2012 | +8.0% | — | — | |
| Q2 2012 | +1.1% | — | — | |
| Q1 2012 | -1.1% | — | — | |
| Q4 2009 | +3.5% | — | — | |
| Q4 2011 | +3.5% | — | — | |
| Q3 2011 | +2.6% | — | — | |
| Q3 2010 | +2.6% | — | — | |
| Q2 2010 | -20.6% | — | — | |
| Q2 2011 | -20.6% | — | — | |
| Q4 2010 | -0.2% | — | — | |
| Q1 2010 | -0.2% | — | — | |
| Q1 2011 | -0.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro